CME Background

Articles are selected for credit designation based on an assessment of the educational needs of CME participants, with the purpose of providing readers with a curriculum of CME articles on a variety of topics throughout each volume. Activities are planned using a process that links identified needs with desired results.

CME Objective

After studying this article, you should be able to:

• Identify the various clinical scenarios in which psychosis and gastrointestinal issues may co-occur

Statement of Need and Purpose

While gastrointestinal issues commonly occur in schizophrenia, gastrointestinal dysfunction and psychotic symptoms may also co-occur in the context of numerous medical and neurologic conditions that have the potential to produce both sets of symptoms. Their co-occurrence spans numerous diagnostic categories. Patients may first present to mental health services; and when gastrointestinal symptoms are severe or functionally problematic, psychiatrists should consider involving other medical services, including primary care physicians, who may be better positioned to coordinate consultation with other relevant specialties. Clinicians need education on the varied contexts in which such symptoms may co-occur, as well as the treatment and clinical implications of making an accurate diagnosis.

Release, Expiration, and Review Dates

This educational activity was published in June 2022 and is eligible for AMA PRA Category 1 Credit™ through June 30, 2023.

Disclosure of Off-Label Usage

The author has determined that, to the best of his knowledge, the listed treatments for cerebrotendinous  xanthomatosis; mitochondrial encephalopathy, lactic acidosis, and stroke-like episodes; and the autoimmune encephalidities discussed, as well as arginine and  cirtrulline in the management of urea cycle disorders, are not approved by the US Food and  Drug Administration for these purposes.

Funding/Support

None